Skip to main content
. 2021 Nov 30;9:25151355211057479. doi: 10.1177/25151355211057479

Figure 4.

Figure 4.

Relative risk versus placebo of SAEs (10 most frequently reported with incidence ⩾0.2% in the RZV group) occurring within 1 year of last vaccination in the combined analysis of the two pivotal Phase-3 trials (ZOE-50 and ZOE-70). 22

Data are reported for the total vaccinated cohort which comprised participants who received at least one vaccine dose.

CI, confidence interval; RR, relative risk; RZV, recombinant zoster vaccine; SAE, serious adverse event.